Showing results (411-420 of 544) with videos related to
Sort By:
Pageof 55
Vaccine: X|November 7, 2022
Comparison of adjuvant emulsions for their safety and ability to enhance the antibody response in horses immunized with African snake venomsMauricio Arguedas, Deibid Umaña, Edwin Moscoso, et al.Vaccine: X|December 1, 2021
Examination of scenarios introducing rubella vaccine in the Democratic Republic of the CongoAlvan Cheng, Kurt Frey, Guillaume Ngoie Mwamba, et al.Vaccine: X|October 10, 2022
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 boosterNapaporn Chantasrisawad, Thanyawee Puthanakit, Katesiree Kornsitthikul, et al.Vaccine: X|October 11, 2022
Trust is the common denominator for COVID-19 vaccine acceptance: A literature reviewBipin Adhikari, Phaik Yeong Cheah, Lorenz von SeidleinVaccine: X|August 29, 2022
Prevalence and management of rubella susceptibility in healthcare workers in Italy: A systematic review and meta-analysisFrancesco Paolo Bianchi, Pasquale Stefanizzi, Giusy Diella, et al.Vaccine: X|September 27, 2022
Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled studyS Mangarule, S Prashanth, A Kawade, et al.Vaccine: X|October 8, 2021
Co-administration of routine paediatric vaccines in England often deviates from the immunisation scheduleJorgen Bauwens, Simon de Lusignan, Julian Sherlock, et al.Vaccine: X|July 20, 2022
Geographical variation of COVID-19 vaccination coverage, ethnic diversity and population composition in FlandersC Faes, G Molenberghs, N Hens, et al.Vaccine: X|July 21, 2022
Vaccine hesitancy and cognitive biases: Evidence for tailored communication with parentsVirginia Casigliani, Dario Menicagli, Marco Fornili, et al.Vaccine: X|March 14, 2022
Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workersNasikarn Angkasekwinai, Jaturong Sewatanon, Suvimol Niyomnaitham, et al.Pageof 55